Partners & Venture Partners
Senior Executive with 28 years experience in devices, diagnostics, and biologics. Vice Chairman of Grifols, Former CEO of Gambro. Senior VP of Baxter Healthcare / Baxter International and President of Baxter Bioscience. Former CEO of HemoCue, which he led to successful exit. Healthcare Advisory Board at Madison Dearborn Partners.
Partner & Managing Director
Formerly head of strategy for medical device company, Gambro. Led and quickly scaled the South East Asia and India device business and led strategic marketing and ICU product development. Investor and advisor to startups. Served as advisor to Longevity Fund, a biotech fund focused on aging.
In previous roles, Peter was President and CEO of Siemens AG, President of Global Human Health and Member of the Executive Board of Merck & Co. Inc., and CEO of GE Healthcare Bio-Sciences. Peter is currently Chairman of the Supervisory Board of OMV and Sulzer AG, as well as Member of the Supervisory Board of Deutsche Bank and Board member of Telefonica S.A.
Director of UCSF’s QB3 startup program and co-founder of Mission Bay Capital. Former Vice Chancellor of UCSF, and Special Advisor for Innovation to the UC school system president.
Founder of the UCSF Rosenman Institute for Medical Device Innovation. Assistant Director, QB3. Held R&D and operations roles at Physiometrix (IPO, then acquired by Hospira), Cardiovasc, and Heartport.
Senior executive in Quality Assurance and Regulatory Affairs for 30 years at Gambro, Toshiba Medical Systems, Bayer Healthcare, Siemens Healthcare Early employee at first MRI company, Daisonic MRI. Advisory board for Neural Analytics and Zenflow.
EIR & Venture Partner
Matthew was previously second employee and CEO of Ulthera, which was acquired by Merz Pharma GmbH for $600M in 2014. Previously, he was President, Baxter Biotech North America, followed by President of Baxter’s Renal Division in the U.S.